Boothbay Fund Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.88M Buy
104,445
+47,992
+85% +$3.05M 0.16% 227
2025
Q4
$3.59M Sell
56,453
-35,363
-39% -$2.2M 0.09% 400
2025
Q3
$5.05M Buy
91,816
+10,020
+12% +$413K 0.13% 315
2025
Q2
$2.7M Sell
81,796
-404
-0.5% -$14.1K 0.08% 428
2025
Q1
$3.3M Sell
82,200
-1,170
-1% -$53.8K 0.11% 311
2024
Q4
$3.92M Sell
83,370
-7,347
-8% -$382K 0.12% 289
2024
Q3
$4.79M Sell
90,717
-2,183
-2% -$122K 0.14% 264
2024
Q2
$5.03M Sell
92,900
-2,979
-3% -$180K 0.15% 224
2024
Q1
$6.72M Buy
95,879
+53,147
+124% +$4.11M 0.19% 152
2023
Q4
$3.57M Buy
+42,732
New +$1.55M 0.12% 306
2023
Q3
Hold
0
1818
2023
Q2
Sell
-11,862
Closed -$417K 1929
2023
Q1
$417K Buy
+11,862
New +$484K 0.01% 1331
2022
Q4
Hold
0
2097
2022
Q3
Sell
-8,762
Closed -$422K 2318
2022
Q2
$344K Buy
+8,762
New +$353K 0.01% 1375
2021
Q3
Sell
-12,217
Closed -$242K 1972
2021
Q2
$242K Sell
12,217
-616
-5% -$14.5K 0.01% 1407
2021
Q1
$298K Sell
12,833
-10,103
-44% -$216K 0.02% 1193
2020
Q4
$477K Buy
+22,936
New +$419K 0.03% 767
2020
Q3
Hold
0
1099
2020
Q2
Hold
0
1015
2020
Q1
Hold
0
905
2019
Q4
Sell
-11,411
Closed -$130K 883
2019
Q3
$130K Buy
+11,411
New +$143K 0.02% 686
2018
Q3
Sell
-18,928
Closed -$157K 832
2018
Q2
$157K Buy
+18,928
New +$158K 0.02% 652
2017
Q4
Hold
0
737
2017
Q3
Hold
0
635

Other funds holding CYTK